Safety study of an extra dose of rimegepant for migraine
Treatments studied
Part of Brain & nervous system, Pain clinical trials.
This study tests whether taking an additional dose of rimegepant (a migraine medicine you may already use) is safe and helpful for adults with migraine. Rimegepant is a calcitonin gene-related peptide (CGRP) receptor antagonist—a type of medicine that blocks a protein involved in migraine pain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have had migraine (with or without aura) for at least 1 year, diagnosed by a doctor
- You currently use an acute migraine treatment (a medicine you take when a migraine starts)
- You have 6–14 migraine days per month on average
- You have fewer than 15 total headache days per month (including migraine and other types)
- You have fewer than 7 non-migraine headache days per month on average
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if the medicine rimegepant is safe for people with migraine. You may be able to join if you have had migraine for at least a year, have 4–14 migraine days per month, and have not had good results with other migraine medicines called triptans.
This Phase 3 study checks the long-term safety of rimegepant, a migraine treatment, in children and teens. You might join if your child has had migraine for at least 6 months and still gets a certain number of moderate-to-severe migraine attacks.
This study tests whether the medication rimegepant can help prevent chronic migraine in adults. It may be an option if you have frequent migraines and have not tried certain other preventive treatments.
This study tests a medicine called rimegepant to see if it helps prevent migraines. If you have migraine at least 4 days per month, this might be for you.
This study tests whether the medicine rimegepant can help prevent migraines that happen around your period. It is for women with regular menstrual cycles who have a history of menstrual migraines.
This trial tests whether a medication called rimegepant can prevent migraines when you take it before a known trigger (like exercise or stress). It is for people who get migraines often and can predict when one might happen.
Hear when a new Acute Treatment of Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.